Geneos Wealth Management’s Invesco BulletShares 2033 Corporate Bond ETF BSCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$79.1K Hold
3,755
﹤0.01% 1303
2026
Q1
$79.4K Hold
3,755
﹤0.01% 1247
2025
Q4
$80.6K Hold
3,755
﹤0.01% 1222
2025
Q3
$80.6K Hold
3,755
﹤0.01% 1198
2025
Q2
$79.6K Hold
3,755
﹤0.01% 1346
2025
Q1
$78.4K Hold
3,755
﹤0.01% 1267
2024
Q4
$77.4K Buy
+3,755
New +$78.9K ﹤0.01% 1150

Other funds holding BSCX

Geneos Wealth Management's BSCX Position: Q2 2026 in Review

Geneos Wealth Management held its Invesco BulletShares 2033 Corporate Bond ETF (BSCX) position steady in Q2 2026 at 3,755 shares worth $79.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1303.

Geneos Wealth Management first reported a position in BSCX in Q4 2024 and has held it in 7 quarters since. The position peaked at $80.6K in Q3 2025. 128 funds tracked by Wall St. Rank hold BSCX as of Q2 2026.

  • Geneos Wealth Management held 3,755 shares of Invesco BulletShares 2033 Corporate Bond ETF worth $79.1K as of Q2 2026.
  • Geneos Wealth Management left its Invesco BulletShares 2033 Corporate Bond ETF share count unchanged in Q2 2026.
  • Invesco BulletShares 2033 Corporate Bond ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1303 holding.
  • Geneos Wealth Management first reported a position in Invesco BulletShares 2033 Corporate Bond ETF in Q4 2024 and has held it in 7 quarters since.
  • Geneos Wealth Management's Invesco BulletShares 2033 Corporate Bond ETF position peaked at $80.6K in Q3 2025.
  • 128 funds tracked by Wall St. Rank held Invesco BulletShares 2033 Corporate Bond ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.